N.J. drugmaker hits roadblock on contraceptive
The Philadelphia Inquirer - Jan 30 12:14 AM
Maybe the maker of Plan B, the aptly named morning-after pill, needs its own backup plan. For years, Barr Pharmaceuticals Inc. has been trying to get its controversial contraceptive approved for sale without a prescription. Named for its purpose – to prevent pregnancy after contraceptive failure or unprotected intercourse – Plan B reduces chances of pregnancy by 89 percent if taken within 72 Save to My Web
Health calendar
The Cincinnati Enquirer - Jan 30 2:47 AM
This week's listing of health-related events.Save to My Web
Sponsors
No Comment
Random Post
Leave Your Comments Below